Microlocalization and clinical significance of stabilin-1+ macrophages in treatment-naïve patients with urothelial carcinoma of the bladder
Open Access
- 13 July 2019
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 38 (3) , 709-716
Abstract
Purpose Emerging evidence has shown that macrophages (Mφs) at different tumor sites have diverse clinical attributes. Stabilin-1 is a multi-functional scavenger marker for specialized tumor-associated Mφs. This study investigates the relationship between the density and microlocalization of stabilin-1+ Mφs within tumors and the clinical outcomes of patients with urothelial carcinoma of the bladder (UCB). Methods In this retrospective study, 283 UCB patients who received radical cystectomy or transurethral resection were examined. Immunohistochemistry and immunofluorescence analyses were used to colocalize the expression of stabilin-1 with other markers for Mφs (CD14, CD68, CD163, and CD206). Kaplan–Meier analysis and Cox proportional hazards regression models were applied to estimate overall survival (OS) and recurrence-free survival (RFS). Results In UCB tissues, stabilin-1 was primarily expressed on Mφs, as evident from triple immunofluorescence staining for stabilin-1 and Mφ markers. Stabilin-1+ Mφs were often more prominent in stromal regions rather than intratumoral regions in UCB tissues (P < 0.0001). After dichotomization at the median cell density for stabilin-1+ Mφs, only intratumoral stabilin-1+ Mφ density was a predictor of poor OS (P < 0.001) and RFS (P = 0.026). Moreover, intratumoral stabilin-1+ Mφ density was positively associated with tumor stage (P < 0.01) and histological grade (P < 0.01), and emerged as an independent prognostic factor for OS (HR 2.371; P < 0.0001), but not for RFS (HR 1.491; P = 0.061). Conclusions Our findings indicate that intratumoral stabilin-1+ Mφs could potentially be used as a pro-tumoral prognostic marker for UCB patients.Keywords
Funding Information
- National Natural Science Foundation of China (81402106, 81825016)
- Science and Technology Program of Guangzhou (201604020177, 201604020156)
- National Natural Science Foundation of Guangdong (2015A030310122)
- Pearl River Nova Program of Guangzhou (201806010024)
- Cultivation of Major Projects and Emerging, Interdisciplinary Fund, Sun Yat-Sen University (16ykjc18)
- Elite Young Scholars Development Program of Sun Yat-Sen Memorial Hospital to Bo Wang; Yat-Sen Scholarship for Young Scientist (none)
- Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun Yat-sen University (KLB09001)
- Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology (013-163)
This publication has 33 references indexed in Scilit:
- NF-κB, inflammation, immunity and cancer: coming of ageNature Reviews Immunology, 2018
- Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder CancerEuropean Urology, 2017
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016European Urology, 2017
- Cancer statistics in China, 2015CA: A Cancer Journal for Clinicians, 2016
- Tissue biology perspective on macrophagesNature Immunology, 2015
- The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancerWorld Journal of Urology, 2015
- Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysisBMC Cancer, 2015
- Origin and Functions of Tissue MacrophagesImmunity, 2014
- A Perspective on Cancer Cell MetastasisScience, 2011
- Laparoscopic Radical Cystectomy with Orthotopic Ileal Neobladder for Bladder Cancer: Oncologic Results of 171 Cases With a Median 3-Year Follow-upEuropean Urology, 2010